Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Fluorescent spray detects fingerprints at crime scenes
Scientists have developed a water-soluble, non-toxic fluorescent spray that makes fingerprints...
NIST develops urine standard for kidney disease diagnosis
In order for doctors to diagnose kidney disease and other conditions that affect kidney function,...
Liquid reagent inactivates SARS-CoV-2 in patient samples
The unique composition of the reagent could extract RNA in patient samples in little as...
